Cancer
Managing cancer and living meaningfully (CALM) in adults with malignant glioma: a proof-of-concept phase IIa trial
Background:
Managing Cancer and Living Meaningfully (CALM) is an evidence-based, brief, semi-structured psychotherapy designed to he...
Identification and prognostic analysis of biomarkers to predict the progression of pancreatic cancer patients
Background:
Pancreatic cancer (PC) is a malignancy with a poor prognosis and high mortality. Surgical resection is the only “c...
Survival trends in chemotherapy exposed metastatic bladder cancer patients and chemotherapy effect across different age, sex, and race/ethnicity
Purpose:
To test for survival differences in metastatic urothelial carcinoma of the urinary bladder (mUCUB) patients, according to y...
Now is the Time to Improve Diversity in Cancer Clinical Trial
Fewer African American and Hispanic patients participated in oncology trials from 2003 to 2016 than from 1996 to 2002.
Fewer African American and...
Safety and Tolerability of Carboplatin and Paclitaxel in Cancer Patients with HIV (AMC-078), an AIDS Malignancy Consortium (AMC) Study
Background:
Persons living with human immunodeficiency virus are an underserved population for evidence-based cancer treatment. Pacl...
Raising Awareness of Leukemia in the Latinx Community
Two types of leukemia—acute lymphocytic (ALL) and acute promyelocytic (APL)—are more widespread in Latinos and more likely to be diagnosed younger,...
Trending Topics
Features
- Drive Toolkit
Download and distribute powerful vaccination QI resources for your community.
- Health Champions
Sign up now to support health equity and sustainable health outcomes in your community.
- Cancer Early Detection
MCED tests use a simple blood draw to screen for many kinds of cancer at once.
- PR
FYHN is a bridge connecting health information providers to BIPOC communities in a trusted environment.
- Medicare
Discover an honest look at our Medicare system.
- Alliance for Representative Clinical Trials
ARC was launched to create a network of community clinicians to diversify and bring clinical trials to communities of color and other communities that have been underrepresented.
- Reducing Patient Risk
The single most important purpose of our healthcare system is to reduce patient risk for an acute event.
